The following slides provide an analysis of the abstracts presented at the AACR 2022 Annual Meeting that were deemed relevant for the Beacon Cancer Vaccine. The abstracts have been split into preclinical and clinical, with further review into the phase distribution, therapeutic class, antigen class and disease indication.
There were 29 drugs evaluated in the 17 preclinical abstracts, and 23 trials related to the 16 clinical abstracts. Find out more by downloading the sample report.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements